FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892959837> ?p ?o ?g. }

• W2892959837 endingPage "17730" @default.
• W2892959837 startingPage "17716" @default.
• W2892959837 abstract "Calpains are intracellular, calcium-activated cysteine proteases. Calpain-3 is abundant in skeletal muscle, where its mutation-induced loss of function causes limb-girdle muscular dystrophy type 2A. Unlike the small subunit–containing calpain-1 and -2, the calpain-3 isoform homodimerizes through pairing of its C-terminal penta-EF-hand domain. It also has two unique insertion sequences (ISs) not found in the other calpains: IS1 within calpain-3’s protease core and IS2 just prior to the penta-EF-hand domain. Production of either native or recombinant full-length calpain-3 to characterize the function of these ISs is challenging. Therefore, here we used recombinant rat calpain-2 as a stable surrogate and inserted IS1 into its equivalent position in the protease core. As it does in calpain-3, IS1 occupied the catalytic cleft and restricted the enzyme’s access to substrate and inhibitors. Following activation by Ca2+, IS1 was rapidly cleaved by intramolecular autolysis, permitting the enzyme to freely accept substrate and inhibitors. The surrogate remained functional until extensive intermolecular autoproteolysis inactivated the enzyme, as is typical of calpain-2. Although the small-molecule inhibitors E-64 and leupeptin limited intermolecular autolysis of the surrogate, they did not block the initial intramolecular cleavage of IS1, establishing its role as a propeptide. Surprisingly, the large-molecule calpain inhibitor, calpastatin, completely blocked enzyme activity, even with IS1 intact. We suggest that calpastatin is large enough to oust IS1 from the catalytic cleft and take its place. We propose an explanation for why calpastatin can inhibit calpain-2 bearing the IS1 insertion but cannot inhibit WT calpain-3. Calpains are intracellular, calcium-activated cysteine proteases. Calpain-3 is abundant in skeletal muscle, where its mutation-induced loss of function causes limb-girdle muscular dystrophy type 2A. Unlike the small subunit–containing calpain-1 and -2, the calpain-3 isoform homodimerizes through pairing of its C-terminal penta-EF-hand domain. It also has two unique insertion sequences (ISs) not found in the other calpains: IS1 within calpain-3’s protease core and IS2 just prior to the penta-EF-hand domain. Production of either native or recombinant full-length calpain-3 to characterize the function of these ISs is challenging. Therefore, here we used recombinant rat calpain-2 as a stable surrogate and inserted IS1 into its equivalent position in the protease core. As it does in calpain-3, IS1 occupied the catalytic cleft and restricted the enzyme’s access to substrate and inhibitors. Following activation by Ca2+, IS1 was rapidly cleaved by intramolecular autolysis, permitting the enzyme to freely accept substrate and inhibitors. The surrogate remained functional until extensive intermolecular autoproteolysis inactivated the enzyme, as is typical of calpain-2. Although the small-molecule inhibitors E-64 and leupeptin limited intermolecular autolysis of the surrogate, they did not block the initial intramolecular cleavage of IS1, establishing its role as a propeptide. Surprisingly, the large-molecule calpain inhibitor, calpastatin, completely blocked enzyme activity, even with IS1 intact. We suggest that calpastatin is large enough to oust IS1 from the catalytic cleft and take its place. We propose an explanation for why calpastatin can inhibit calpain-2 bearing the IS1 insertion but cannot inhibit WT calpain-3." @default.
• W2892959837 created "2018-10-05" @default.
• W2892959837 creator A5035023245 @default.
• W2892959837 creator A5045577140 @default.
• W2892959837 creator A5049581351 @default.
• W2892959837 creator A5055689189 @default.
• W2892959837 date "2018-11-01" @default.
• W2892959837 modified "2023-10-17" @default.
• W2892959837 title "Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide" @default.
• W2892959837 cites W1496031212 @default.
• W2892959837 cites W1500880970 @default.
• W2892959837 cites W1540831369 @default.
• W2892959837 cites W1546503260 @default.
• W2892959837 cites W1594694014 @default.
• W2892959837 cites W1615094203 @default.
• W2892959837 cites W1639940444 @default.
• W2892959837 cites W1700813235 @default.
• W2892959837 cites W1818565127 @default.
• W2892959837 cites W1863930712 @default.
• W2892959837 cites W1925868689 @default.
• W2892959837 cites W1966992730 @default.
• W2892959837 cites W1967791344 @default.
• W2892959837 cites W1971896446 @default.
• W2892959837 cites W1976575500 @default.
• W2892959837 cites W1980646317 @default.
• W2892959837 cites W1984185548 @default.
• W2892959837 cites W1985731867 @default.
• W2892959837 cites W1987293058 @default.
• W2892959837 cites W1987485970 @default.
• W2892959837 cites W1987606664 @default.
• W2892959837 cites W1989284694 @default.
• W2892959837 cites W1991487249 @default.
• W2892959837 cites W1991569079 @default.
• W2892959837 cites W1993528483 @default.
• W2892959837 cites W1997151018 @default.
• W2892959837 cites W2003681285 @default.
• W2892959837 cites W2004174813 @default.
• W2892959837 cites W2007047797 @default.
• W2892959837 cites W2010000399 @default.
• W2892959837 cites W2011924601 @default.
• W2892959837 cites W2013622558 @default.
• W2892959837 cites W2013687984 @default.
• W2892959837 cites W2013843427 @default.
• W2892959837 cites W2017492488 @default.
• W2892959837 cites W2019203239 @default.
• W2892959837 cites W2023380188 @default.
• W2892959837 cites W2024993897 @default.
• W2892959837 cites W2029318279 @default.
• W2892959837 cites W2029955024 @default.
• W2892959837 cites W2032652036 @default.
• W2892959837 cites W2034663071 @default.
• W2892959837 cites W2038721029 @default.
• W2892959837 cites W2040698692 @default.
• W2892959837 cites W2046968011 @default.
• W2892959837 cites W2048978352 @default.
• W2892959837 cites W2055782143 @default.
• W2892959837 cites W2059771393 @default.
• W2892959837 cites W2060953087 @default.
• W2892959837 cites W2061294083 @default.
• W2892959837 cites W2063795609 @default.
• W2892959837 cites W2081796662 @default.
• W2892959837 cites W2092115901 @default.
• W2892959837 cites W2100143162 @default.
• W2892959837 cites W2112160057 @default.
• W2892959837 cites W2119579078 @default.
• W2892959837 cites W2121532618 @default.
• W2892959837 cites W2128512272 @default.
• W2892959837 cites W2131499490 @default.
• W2892959837 cites W2134585388 @default.
• W2892959837 cites W2142520482 @default.
• W2892959837 cites W2148220372 @default.
• W2892959837 cites W2149194169 @default.
• W2892959837 cites W2151185644 @default.
• W2892959837 cites W2153451334 @default.
• W2892959837 cites W2158904461 @default.
• W2892959837 cites W2162715315 @default.
• W2892959837 cites W2163887032 @default.
• W2892959837 cites W2164571708 @default.
• W2892959837 cites W2165635086 @default.
• W2892959837 cites W2169171785 @default.
• W2892959837 cites W2169436026 @default.
• W2892959837 cites W2170546945 @default.
• W2892959837 cites W2179722004 @default.
• W2892959837 cites W2270020113 @default.
• W2892959837 cites W2550827765 @default.
• W2892959837 cites W2567060336 @default.
• W2892959837 cites W2579220055 @default.
• W2892959837 cites W2785752848 @default.
• W2892959837 cites W295479257 @default.
• W2892959837 cites W3216487833 @default.
• W2892959837 doi "https://doi.org/10.1074/jbc.ra118.004803" @default.
• W2892959837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6240860" @default.
• W2892959837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30254072" @default.
• W2892959837 hasPublicationYear "2018" @default.
• W2892959837 type Work @default.
• W2892959837 sameAs 2892959837 @default.
• W2892959837 citedByCount "6" @default.
• W2892959837 countsByYear W28929598372020 @default.

• next